🇺🇸 FDA
Patent

US 8981057

B-cell stimulating fusion proteins of an antigen with BAFF or APRIL

granted A61KA61K2039/55516A61K38/00

Quick answer

US patent 8981057 (B-cell stimulating fusion proteins of an antigen with BAFF or APRIL) held by ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM
Grant date
Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/55516, A61K38/00, A61K38/191, A61K39/00